Headaches Clinical Trial
— VHSOfficial title:
Patients` Satisfaction With Telemedicine Versus Traditional Specialist Consultation for Headache. An Open-labeled Randomized Non-inferiority Study Among Patients With Headache Referred to a Neurologic Outpatient Clinic
Headache is a frequent cause of visits to the GPs office, and the investigators have
previously shown that this group accounts for about 20 % of patients referred to a general
neurologic outpatient clinic.
To our knowledge, no previous study has investigated whether headache consultation through
telemedicine provides equal health care outcomes compared to regular visit to the
neurologist. If that's the case, a modern interactive health care system may give simpler
and cheaper services for patients, saving travelling costs and community expenses. It may
possibly also lead to reduced waiting lists, earlier diagnosis and treatment.
This is an open-labeled randomized non-inferiority trial of headache patients referred to a
neurologic clinic in North-Norway. The aim of this study is to determine whether video
consultations are non-inferior to regular consultations in diagnosing and treating primary
headaches. The null hypothesis is that there is no difference in patient satisfaction
between the two groups. The outcome is assessed 3 and 12 months after the neurologic
consultation.
Participants will be allocated to either a telemedicine consultation or a regular
consultation at the neurologic outpatient clinic in the University Hospital of North-Norway,
Tromsø. Both groups will undergo a structured and detailed interview to clarify the
diagnosis and establish appropriate treatment. To ensure the best possible representation in
the population, our goal is to include at least 70% of all the referred patients that meet
the criteria for participation. The randomizations are made through a centralized 8-16 phone
line to the research-department in Tromsø, at the University Hospital of North-Norway.
Both primary and secondary endpoints will be assessed in questionnaires sent three and 12
months after the consultation. In addition, the quality of the physicians` referrals and
calculations of cost savings by using telemedicine will be evaluated.
The patients' informed consent will always be obtained before data collection. Patients are
able to withdraw from the study at any time. Withdrawal will not affect the treatment or
follow up. Local research ethics committee (REC) has approved the study.
Status | Completed |
Enrollment | 402 |
Est. completion date | June 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 16 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Females and males =16 and =65 years of age - Referred to a neurologist for headache - No red flags (defined) suggestive of a secondary cause? No known underlying causes of headaches (secondary headaches) according to established criteria - Referred for diagnostic clarification and / or treatment - Waiting time = 4 months from the date of the referral - speaking Norwegian language Exclusion Criteria: - Age <16 years or > 65 years of age - Known underlying cause of the headache or the presence of red flags suggestive of secondary headaches. - Examined by a neurologist for headaches in a period of 2 years before referral - Waited longer than 4 months from the date of referral - Non-Norwegian speaker |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Norway | Department of Neurology, University Hospital of North Norway | Tromsø | Troms |
Lead Sponsor | Collaborator |
---|---|
University Hospital of North Norway | University of Tromso |
Norway,
Bekkelund SI, Albretsen C. Evaluation of referrals from general practice to a neurological department. Fam Pract. 2002 Jun;19(3):297-9. — View Citation
Bekkelund SI, Salvesen R. Is uncertain diagnosis a more frequent reason for referring migraine patients to neurologist than other headache syndromes? Eur J Neurol. 2006 Dec;13(12):1370-3. — View Citation
Bekkelund SI, Salvesen R. Patient satisfaction with a neurological specialist consultation for headache. Scand J Prim Health Care. 2002 Sep;20(3):157-60. — View Citation
Bekkelund SI, Salvesen R; North Norway Headache Study (NNHS). Are headache patients who initiate their referral to a neurologist satisfied with the consultation? A population study of 927 patients--the North Norway Headache Study (NNHS). Fam Pract. 2001 Oct;18(5):524-7. — View Citation
Cottrell C, Drew J, Gibson J, Holroyd K, O'Donnell F. Feasibility assessment of telephone-administered behavioral treatment for adolescent migraine. Headache. 2007 Oct;47(9):1293-302. — View Citation
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9-160. — View Citation
Pryse-Phillips W. Evaluating migraine disability: the headache impact test instrument in context. Can J Neurol Sci. 2002 Jun;29 Suppl 2:S11-5. Review. — View Citation
Salvesen R, Bekkelund SI. Aspects of referral care for headache associated with improvement. Headache. 2003 Jul-Aug;43(7):779-83. — View Citation
Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010 Aug;11(4):289-99. doi: 10.1007/s10194-010-0217-0. Epub 2010 May 16. Review. — View Citation
Stovner LJ, Andrée C; Eurolight Steering Committee. Impact of headache in Europe: a review for the Eurolight project. J Headache Pain. 2008 Jun;9(3):139-46. doi: 10.1007/s10194-008-0038-6. Epub 2008 Apr 17. Review. — View Citation
Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol. 2006 Apr;13(4):333-45. Review. — View Citation
* Note: There are 11 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Estimation of travelling distances to the neurologic outpatient clinic | travelling distances in kilometers | travelling distance in kilometers for the neurologic consultation (telemedicine versus regular consultation) and the average travelling distance to the GP during the consecutive 11 months | No |
Other | Expenses saved by using telemedicine | Evaluation of the expenses associated with telemedicine compared to regular consultations (travelling expensis, lost earnings, days away from work, | Expenses (travelling, lost income and days absent from work) for the neurologic consultation and the average expenses for GP-consultations during the consecutive 11 months | No |
Other | Number of headache days and headaches | Change in number of headache days per month and number of headahces per month | change in number of headaches from baseline, at 3 months and 12 months | No |
Other | Change in headache feature | Is the headahce bether, worse or the same. Is the headahce more intens, less intens or unchanged. | Change in headache features from baseline, after 3 months and 12 months | No |
Primary | Number of satisfied participants | Are you satisfied with the consultation? Yes/No | change from baseline at 3 months and 12 months | No |
Secondary | VAS satisfaction rating scale | Visual analog satisfaction scale 0-10, where 0 = least satisfied and 10 = most satisfied | 12 months | No |
Secondary | VAS pain scale | Headache measured by a visual analog scale 0-10, 0= no pain, 10=worst pain | changes from baseline in VAS at 3 months and 12 months | No |
Secondary | HIT-6 | Headache impact test | Changes from baseline in HIT 6 at 3 months and 12 months | No |
Secondary | Job situation/occupation | Job situation/occupation | changes from baseline in job situation at 3 months and 12 months | No |
Secondary | numbers of consultations during follow up | numbers of GP-consultations, hospital consultations and admissions | numbers of consultations from baseline and after 12 months | No |
Secondary | number of pain killers, triptans and other medications for headache | number of medications for headache | at baseline, after 3 months and after 12 months | No |
Secondary | headache diagnosis | Headache diagnosis after IHS criteria | at baseline, after 3 months and 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00956969 -
Stress Management for Chronic Headaches
|
N/A | |
Completed |
NCT00475189 -
Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills)
|
N/A | |
Terminated |
NCT02638506 -
RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches
|
Phase 4 | |
Completed |
NCT00484029 -
Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain
|
Phase 2 | |
Completed |
NCT01667679 -
Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without
|
Phase 3 | |
Completed |
NCT00921453 -
Tailored Internet Information Supply for Patients - Part 2
|
N/A | |
Completed |
NCT00067249 -
Women's Use of Alternative Medicine: A Multiethnic Study
|
N/A |